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ABSTRACT  
Most tissue-resident macrophages (Mφs) are believed to be derived prenatally and assumed to 
maintain themselves throughout life by self-proliferation. However, in adult mice we identified a 
novel progenitor within bone marrow early pro-B cell/fraction B that differentiates into tissue Mϕs. 
These Mφ precursors have non-rearranged BCR genes and co-express myeloid (GR1, CD11b and 
CD16/32) and lymphoid (B220 and CD19) lineage markers. During steady state these precursors 
exit bone marrow losing Gr1 and enter systemic circulation seeding the gastrointestinal system as 
well as pleural and peritoneal cavities but not the brain. Whilst in these tissues they acquire a 
transcriptome identical to embryonically derived tissue-resident Mφs. Similarly, these Mϕ 
precursors also enter sites of inflammation gaining CD115, F4/80 and CD16/32 and become 
indistinguishable from blood monocyte-derived Mϕs. Thus, we have identified a population of cells 
within bone marrow early pro-B cell compartment that possess functional platicity to differentiate 
into either tissue-resident or inflammatory Mφs depending on micro-environmental signals. We 
propose that these precursors represent an additional source of Mφ populations in adult mice 
during steady state and inflammation.   
 
 
 
  
 
 
 3
SIGNIFICANCE STATEMENT 
In this report we provide evidence of a novel source of macrophage populations that are derived 
from a unique bi-phenotypic early pro-B cells with non-re-arranged BCR. These early precursors 
give rise to either tissue resident- or monocyte-derived macrophages during homeostasis and 
inflammatory responses thereby demonstrating functional plasticity depending on the 
environmental cues in adult mice. We suggest that these data significantly advance and expand 
our understanding of Mφ biology and haematopoiesis, the plasticity of hematopoietic precursors 
and the heterogeneity of Mφ subsets. 
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INTRODUCTION 
Monocytes and Mφs maintain tissue homeostasis and orchestrate immune mediated responses to 
infection/injury. During embryonic haematopoiesis monocytes arise from myeloid precursors in 
foetal liver while during adulthood they are derived from bone marrow progenitors. Circulating 
monocytes migrate to sites of infection/injury where they differentiate into Mφs(1, 2) and under 
certain circumstances can also replenish Mφs in the colon(3). In contrast, the majority of resident 
Mφ populations are embryonically derived and are proposed to maintain their numbers by local 
proliferation after birth(4-9). However, in the course of our studies we identified a population of 
biphenotypic Mφs in the serous cavities of naive mice that co-express the B lineage marker CD19 
and the Mφ markers CD11b and F4/80. Interestingly, revised models of haematopoiesis(10, 11) 
and evidence of developmental plasticity within haematopoietic precursors suggest a closer 
developmental relationship between myeloid and lymphoid lineages than previously 
appreciated(10-14). Consequently, as there is convincing evidence that lymphocyte-to-Mϕ 
differentiation can occur in vitro under artificial experimental settings(15-19), we determined 
whether the biphenotypic cells we observed in the peritoneal and pleural cavities as well as the 
gastrointestinal system were derived from B-lymphocytes or precursors within the B cell lineage. If 
so, this would challenge the existing view that local self-proliferation is the only means by which 
tissue-resident Mϕs maintain their numbers throughout adulthood.     
 
Using a range of B cell lineage-specific transgenic reporter mice as well as single cell PCR, 
ImageStream/polychromatic flow cytometry and adoptive transfer studies, our data show that 
contrary to previous publications(16, 18, 19) mature B cells do not differentiate into Mϕs. Instead, 
we found a population of cells within the early pro-B cell/fraction B cell compartment with non-
rearranged BCR genes that exit bone marrow under steady state, circulate in peripheral blood and 
populate serous cavities where they differentiate into Mϕs thereby contributing to the overall pool 
of tissue Mϕs alongside embryonically-derived cells. Hence, in addition to local proliferation, we 
now further refine our understanding of how tissue Mϕs numbers are maintained during adulthood. 
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Moreover, these data report a novel cell with origins that are morphogenically distinct from 
embryonic Mϕ precursors, but that nonetheless differentiate in to cells with equivalent phenotypes. 
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RESULTS 
Mφs with a potential B cell origin detected using Mb1-iCre/Rosa26R-YFP reporter mice  
Analysis of cells from the peritoneal cavity of naïve wild-type mice revealed a population of 
F4/80++CD11b++ Mφs that also expressed CD19 (Fig. 1A). These cells constitute ~0.8% of total 
Mφs suggesting a potential developmental relationship between mononuclear phagocytes and B 
cells. Crossing Mb1-iCre(20) with Rosa26-YFP(21) mice allowed us to investigate this potential 
further as Mb1-dependent Cre-recombinase expression is induced in B cells during the very early 
pro-B stage(20). Thus, tissue Mφs that express YFP will have been derived from B cells. In naive 
Mb1-iCre/Rosa26-YFP mice a significant proportion of Mφs expressed YFP including ~25% of 
peritoneal Mφs, 4-10% of pleural cavity Mφs and 1-2.5% of intestinal Mφs, with very few YFP+ Mφs 
detectable in the spleen, liver and brain (Fig. 1B); gating strategies to discern tissue Mϕ 
populations are shown in supplementary Fig. 1.1. 
 
To determine B cell lineage restricted reporter expression in Mb1-iCre/Rosa26-YFP mice we 
analysed YFP expression in various hematopoietic progenitors of these animals as well as mature 
leukocytes in various tissue compartments. Analysis revealed that 97-99% of peripheral blood B 
cells were YFP+ with only minimal YFP expression detected on T cells and monocytes with no YFP 
expression detectable on neutrophils (supplementary Fig. 1.2A). In bone marrow we found ~7% 
of YFP+ cells among Lin-IL7Rα+Sca-1+c-Kit+ common lymphoid progenitors (CLP), but no YFP+ 
cells was detected among Lin-IL7Rα-CD34+/-CD16/32+ common myeloid progenitors (CMP). 
Equally, there was no YFP expression detectable in Lin-IL7Rα-Sca-1++c-Kit++ multi-lineage 
progenitors (MLP) and Lin-IL7Rα-CD34+CD16/32++ granulocyte/ Mφs progenitors (GMP) 
(supplementary Fig. 1.2B). More specifically, the lymphoid-biased multipotent progenitor (LMPP, 
Lin-IL7Rα-Flk-2hiCD34+) was found to be negative (supplementary Fig. 1.2B). Finally, ~0.15% YFP+ 
cells was detected in Lin-CD4-CD8- early thymic progenitors (supplementary Fig. 1.2C). Gating 
strategies for flow cytometric identification of hematopoietic progenitors in bone marrow and T cell 
progenitors in thymus are shown in supplementary Figs 1.3 and 1.4. 
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Phagocytosis of apoptotic YFP+ B cells by Mφs does not generate YFP+ Mφs 
Immunofluorescent microscopy on FACS-purified peritoneal cell populations as well as in vitro 
phagocytosis assays where YFP- Mφs were co-cultured with early/late apoptotic YFP+ B cells 
confirmed that the YFP fluorescence detected in YFP+ Mφs from Mb1-iCre/Rosa26-YFP mice was 
due to the cytoplasmic YFP expression in Mφs and not from ingestion of apoptotic YFP+ B cells 
(supplementary Fig 2A-E). 
 
YFP+ Mφs in Mb1-iCre/Rosa26R-YFP mice do not arise form mature B cells  
Hematopoietic development of B cells includes seven stages (A to C, C’ to F), which are defined by 
stage-specific cell surface marker expression and B cell receptor (BCR) gene rearrangement 
status(22, 23). Rearrangement of Ig genes, which is initiated during bone marrow development at 
pro-B cell stage/fraction B stage and completed in pre-B/fraction C’ B cells(23) leads to surface 
expression of BCRs of unique DNA sequence and enables B cell development and survival(24). 
This distinctive feature of B cell development was exploited to determine whether YFP+ Mφs carry 
V-DJ re-arrangements in their IgH locus as evidence of their origin from mature/pre B cells.  
 
Before embarking upon single cell PCR to determine whether YFP+ Mϕs carry V-DJ re-
arrangements we ensured that cell populations we intended to FACSort were single cells and not 
doublets/clusters of Mϕs with YFP+ B cells. Previous studies have reported biphenotypic murine 
peritoneal Mφs co-expressing F4/80 and CD11b along with surface IgM, CD5, CD19 and/or 
B220(25-27), but without considering the possibility of cell doublets/clusters generating potential 
false-positive data. ImageStream analysis of the murine peritoneum identified three distinct cell 
types within the CD11b++F4/80++ Mφ gate including CD19-YFP- (embryonic Mφs), CD19-YFP+ and 
CD19+YFP+ cells (Fig. 2A). It’s this latter biphenotypic Mφ population co-expressing CD11b, F4/80, 
YFP and CD19 that we suspect are intermediates in the transition of B cells to Mφs. However, 
ImageStream also revealed significant numbers of doublets (Mϕ/B cell clusters) within this 
intermediate CD19+YFP+ Mφ population, with single biphenotypic cells constituting only ~16.74% of 
the total CD19+YFP+ Mφs (Fig. 2B and Table), meaning that approximately 80% cells within the 
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biphenotypic population are aggregates of Mϕs and B cells. See supplementary Fig 3.1 for further 
data on identifying clusters/doublets.  
 
Therefore, we sorted CD19-YFP- (embryonic Mφs), CD19-YFP+ and intermediate CD19+YFP+ 
biphenotypic cells along with B cells to act as a positive control bearing in mind that the 
intermediate or biphenotypic cells contain random clusters of Mϕ/B cell aggregates. On a single 
cell level, while V-DJ re-arrangements were detected in ~71% of single B cells analysed, only 
~33% of intermediate CD19+YFP+ Mφs were V-DJ+ with no re-arrangements found in CD19-YFP+ B 
cell-derived Mφs or CD19-YFP- tissue-resident embryonic Mφs (Fig. 2C). A significant increase in 
the frequency of V-DJ+ reactions in the CD19+YFP+ populations was found, which increased from 
33% to 84% (compared to ~87% for B cells) when multiple cells (5, 10 or 20) per reaction were 
analysed. We propose that this arose from contaminating B cells or B cell/Mφ clusters in at least 
~33% of single-sorted B-Mφ intermediate CD19+YFP+ Mφs. As expected all single B cells 
expressed Cd79b while CD19-YFP+ B cell-derived Mφs and CD19-YFP- tissue-resident embryonic 
Mφs expressed Emr1 (encoding the Mφs marker F4/80). Unlike other Mφ subsets, co-expression 
of the B cell-specific transcript Cd79b and the Mφs-specific transcript Emr1 was detected in 
intermediate CD19+YFP+ Mφs on a single cell level. Collectively, these data show that YFP+ 
macrophages display no evidence of VDJ recombination and that VDJ recombination detected in 
CD19+YFP+ Mφs arises from sorting of doublets/clusters. 
 
Of note, single cell PCR reported doublet rates of ∼30% while ImageStream estimated ∼80%. This 
disparity arises from the different algorithms flow cytometry uses for single cell sorting (for PCR) 
compared to ImageStream. Nonetheless, both methods reliably identified the presence of 
contaminating B cell/Mφ clusters within the intermediate CD19+YFP+ Mφ population, which, in the 
absence of stringent exclusion criteria, will generate false positive results. 
 
. 
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Evaluation of B cell-specific reporter mice point toward early pro-B cell origin of YFP+ Mφs  
We analysed bone marrow of Cd19-Cre/Rosa26-YFP mice using the gating strategy in 
supplementary Fig. 4.1A. In these animals although surface CD19 is expressed from early pro-B 
cell stage/fraction B onwards (supplementary data Fig. 4.1B), only ~15% of this B cell subset 
was YFP+ (Fig. 3A). However, in these animals Cre expression increases at later stages of bone 
marrow development compared to Mb1-iCre/Rosa26-YFP strain(28) resulting in ~90% YFP 
labelling detectable in mature B/fraction F cells (Fig. 3A). In these mice, while YFP expression was 
found in ~90% of peritoneal B cells from Cd19-Cre/Rosa26-YFP mice, very small numbers of YFP+ 
Mφs were found in this Cd19-Cre reporter strain; similar data were obtained using Cr2-Cre reporter 
mice where YFP expression is also restricted to mature B cell populations (Fig. 3B). These data 
along with those in Fig. 2C (no V-DJ re-arrangements detectable in YFP+ Mϕs) suggest that YFP+ 
Mϕs found in Mb1-iCre/Rosa26-YFP mice are not derived from mature B cells. 
 
Next we investigated whether YFP+ Mφs developed in Mb1-iCre/Rosa26-YFP mice that were also 
deficient in Rag2 gene and therefore lacked mature B cells due to a developmental block at the 
bone marrow pro-B cell stage(29). The frequency of YFP+ Mφs in the peritoneal cavity of Rag2-/-
/Mb1-iCre/Rosa26-YFP were similar to those detected in B cell-sufficient Rag2+/+/Mb1-
iCre/Rosa26-YFP mice (Fig. 3B). These data and those presented in Fig. 2 suggest that tissue-
resident YFP+ Mφs are not derived from mature B cells, but arise from an immature B cell 
population with non-rearranged BCR genes, most likely within pro-B cells. As a proportion of early 
pro-B/fraction B cells have not undergone rearrangement(30), we suspect that it’s this population 
that harbour novel precursors that are an alternative source of Mϕs in adulthood. 
  
In support of this hypothesis we found B220+CD43+ early B cells in bone marrow (Fig. 4A) as well 
as in blood (Fig. 4B) that were also CD19+YFP+CD16/32++CD11b+. High levels of CD16/32 and 
CD11b expression, which are commonly found on myeloid cell populations (supplementary Fig. 
4.2), suggest that this population might be a potential precursor of YFP+ Mφs. Indeed, back-gating 
analysis revealed that these cells are found within early pro-B/fraction B cells in the bone marrow 
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(Fig. 4C). The majority of these cells in bone marrow were also Gr1+, while only ~30% expressed 
Gr1 in blood; both bone marrow and blood cell populations expressed very little, if any, IL7Rα 
(supplementary Fig.  4.3B).  
 
Therefore, the absence of YFP+ Mφs in Cd19-Cre/Rosa26-YFP, but their presence in Rag2-/-/Mb1-
iCre/Rosa26-YFP mice suggests that YFP+ Mφs in Mb1- iCre/Rosa26-YFP mice might be derived 
from non-rearranged B220+CD43+CD19+YFP+CD16/32++CD11b+ cells within early pro-B/Fraction B 
cells. Consequently, YFP+ Mφs are hereafter referred to as “pB-Mφs” for cells derived from a 
population within early pro B cells. In addition, B220+CD43+CD19+YFP+CD16/32++CD11b+ B cells 
that give rise to pB-Mφs are called “pB-Mφprecursors”. 
 
Pro-B cell-derived Mφs are generated in response to inflammation 
To determine the dynamic relationship between pB-Mφprecursors and pB-Mφs we injected 
zymosan(31) into the peritoneum of Mb1-iCre/Rosa26-YFP mice. Zymosan triggers an acute 
resolving inflammation causing immediate changes in cellular trafficking within the peritoneum as 
well as in blood and bone marrow. In the naïve peritoneum and shown previously in Fig. 1B, YFP- 
embryonic-derived Mφs as well as YFP+ pB-Mφs were identified within the B220-CD19- fraction; 
however, both populations were also CD16/32++. Within B220+CD19+ B cells a subset that co-
expressed CD16/32++CD11b++ and YFP+ was identified (Fig. 5A). This latter population was 
phenotypically similar to pB-Mφprecursors in bone marrow and blood (Fig. 4A-B). After 4h of zymosan 
injection CD19-YFP- embryonic Mφs and pB-Mφs transiently disappeared from the peritoneum 
consistent with the “leukocyte disappearance phenomenon”(32) while numbers of peritoneal pB-
Mφprecursors  increased at onset, but declined from 24 to 72h after zymosan injection (Fig. 5B); the 
temporal profiles of these cells are shown in Fig. 5C.  
 
pB-Mφprecursors detected within the B cell compartment at 4h underwent phenotypic changes over 
the course of inflammation by down-regulating expression of Gr1 and CD43, but up-regulating 
CD115, F4/80 and CD16/32 (Fig. 5D).  As pB-Mφprecursors differentiated into Mφs from 24h after 
zymosan administration they lost CD19 and B220 expression and acquired Mφ characteristics 
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including expression of F4/80 and higher levels of CD11b and CD16/32 coincident with the 
increase in the numbers of pB-Mφs from 24h onwards, Fig. 5D.  
 
Consistent with the idea that biphenotypic cells within bone marrow pro-B/Fraction B gives rise to 
YFP+ Mφ, the proportion of pB-Mφprecursors in bone marrow increased at 4h post-peritonitis and 
gradually returned to pre-inflammation levels by 72h (Fig. 5D). Changes in peripheral blood pB-
Mφprecursors correlated inversely with the fluctuations in bone marrow pB-Mφprecursors demonstrating a 
transient decrease at inflammatory onset and recovery by resolution (Fig. 5E). These data, taken 
together with an increase in peritoneal pB-Mφprecursors during the early stage of inflammation (Fig. 
5C) reflect the generation and expansion of bone marrow pB-Mφprecursors triggered by inflammation 
followed by their migration via the blood stream into the peritoneum and their further differentiation 
into inflammatory pB-Mφ.  
 
We next tested the potential of pB-Mφprecursors to proliferate in either myeloid or lymphoid cocktails 
over 14 days in culture. Using CMPs and proB cells as controls, pB-Mφprecursors grow only in a 
myeloid cocktail and did not respond to growth factors that support lymphocyte growth, Fig 6A; this 
is consistent with virtually undetectable levels of IL7Ra on these cells, Supplementary Fig. 4.3C. 
We also tested the ability of FACS-purified peritoneal pB-Mφprecursors to differentiate into Mφs in 
vitro. We used pB-Mφprecursors collected at 4h post-peritonitis as they were quantitatively enriched 
during that phase when compared to the naïve peritoneum; naïve peritoneal B cells (CD19+Gr1-
CD11b+/-F4/80-) were used as control. After 6 days of cultivation in presence of M-CSF small and 
distinctively round pB-Mφprecursors differentiated into cells with characteristic Mφ morphology as they 
increased their cell size and acquired F4/80 expression (Fig. 6B-C). Significantly fewer cells 
acquired these Mφ characteristics when cultivated in the absence of M-CSF or presence of GM-
CSF (Fig. 6C and for further comparisons see Supplementary Fig. 5.1). 
 
Early pro-B cells reconstitute tissue Mφs in vivo following lethal irradiation 
FACS-purified bone marrow YFP+ early pro-B/fraction B cells comprising biphenotypic 
CD19+B220+YFP+CD16/32++CD11b+ pB-Mφprecursors (Fig. 4A and supplementary Fig. 6.1) were 
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injected into lethally irradiated wild type mice along with CD45.1+ total bone marrow from congenic 
wild type mice to improve survival rates following irradiation. Mature bone marrow B cell/fraction F 
subset (supplementary Fig. 6.1) in combination with CD45.1+ total bone marrow was used as a 
control. Data in Fig. 7A depicts B cell and Mϕ composition of the peritoneum of naïve wild type 
CD45.1 mice alongside Mb-1iCre/Rosa26-YFP mice, which are on a CD45.2 background. Adoptive 
transfer of CD45.1+ bone marrow resulted in reconstitution of all lineages, while early pro-B cells 
contributed to the restoration of B cell lineage in the peritoneum (Fig. 7B) and spleen (Fig. 7C). 
Importantly, adoptively transferred biphenotypic pB-Mφprecursors within early pro-B cells gave rise to 
YFP+ Mφs in the peritoneum, but did not contribute to myeloid populations in the spleen (Fig. 7C 
and supplementary Fig. 6.2 B and C). While YFP expression was found in roughly 7% of CLPs 
(supplementary Fig. 1.2B) there was no YFP+ mature T cells found in the spleens of recipient 
mice (Fig. 7C); moreover, transfer of Lin-IL7Rα+Sca-1++c-Kit++ CLPs containing YFP+ CLPs to 
lethally irradiated mice did not result in the appearance of YFP+ Mϕs in these animals (Fig. 7D). 
Also, upon the transfer of Mb-1iCre/Rosa26-YFP LMPPs into sublethally-irradiated CD45.1+ Rag2-
null recipients no evidence of the reporter was found in the hosts (Table S1), consistent with 0% 
YFP reporter expression in these cells, Supplementary Fig. 1.2B. These findings provide 
evidence that early pro-B cells and specifically biphenotypic pB-Mφprecursors and not mature B cells 
or contaminating CLPs differentiate into Mφs in vivo. 
 
Transcriptomic analysis of pro-B cell-derived Mφs and their ‘classical’ counterparts 
In the first instance, it was necessary to discriminate between Mφ populations present in the naïve 
peritoneum and those that appear during inflammatory resolution. To do this we used the 
phagocytic dye PKH26PCL (PKH-Red), which labels resident peritoneal phagocytes(33) but not 
infiltrating pB-Mφprecursors or peripheral blood monocytes (supplementary Fig. 7.1). Embryonically 
derived Mφs and pB-Mφs were further designated as MφsTR-naïve (P1) and pB-MφsTR-naïve (P2), 
respectively, to highlight they are Tissue Resident cells from the naïve peritoneum. Injecting PKH-
Red into Mb1-iCre/Rosa26-YFP mice prior to inflammation resulting MφsTR-naïve and pB-MφsTR-naïve 
becoming PKH-PCL positive. Injecting zymosan shortly after PKH-PCL and examining the cavity 
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during resolution revealed four additional inflammatory Mφ populations including MφsTR-naïve that 
experienced 72h of inflammation and are hereafter called MφsTR-inflam (P3) and monocyte-derived 
mo-Mφsinflam (P4) as they are YFP-PKH-. In addition, pB-MφsTR-naïve that experienced 72h of 
inflammation were detected and named pB-MφsTR-inflam (P5) while pB-Mφprecursors that infiltrated into 
the cavity in response to zymosan (evident at 4h in Fig. 5B) and that also experienced 72h of 
inflammation were detected and designated pB-Mφsinflam (P6), Fig. 8A.     
 
Gene expression profiles for these naïve and inflammation-experienced Mϕ populations were then 
analysed, see Methods section for microarray and sample preparation as well as supplementary 
Figs. 7.2-7.3 for gating strategies. First, we compared global gene expression profiles of individual 
cell populations (30 datasets, n=3 per group) by performing a sample-to-sample correlation 
analysis using the Biolayout Express3D software tool(34) with a Pearson correlation threshold of r 
≥ 0.97. This analysis showed that monocytes, neutrophils, B-1 and B-2 B cells data sets (these 
additional cells types were included for comparison purposes) clustered together like-with-like in 
distinct regions of the graph, while all Mφ populations formed a single, distinct component within 
this network (Fig. 8B). Within this component, naïve tissue-resident pB-MφTR-naïve and MφTR-naïve 
were located like-with-like as were inflammatory tissue-resident pB-MφTR-inflam and MφTR-inflam as 
well as inflammation-induced pB-Mφinflam and mo-Mφinflam. These data suggest that pB-Mφs and 
‘classical’ Mφs that are embryonically derived share highly similar overall transcriptional profiles. 
Network correlation and cluster analysis of transcript co-expression shown in Fig. 8C revealed 
gene clusters with similar functions or cell-specific activities occupying specific cliques within the 
network graph. Table S2 provides the contents of each of these clusters, and the expression 
profiles of selected clusters across the 30 data sets are displayed in supplementary data Fig. 7.5 
A-D and supplementary Fig. 7.4. For example, cluster C2 and C4 contained many genes 
expressed highly by B cells (supplementary data Fig. 7.5A) including Cd19 and many 
immunoglobulin-encoding genes including IgH-V11 supplementary data Fig. 7.5B). Clusters C5, 
C17, and C50 were enriched with genes known to be expressed highly by Mφs(35) 
(supplementary data Fig. 7.5C). Genes within these clusters were expressed highly by all 
monocyte and Mφ populations represented in this analysis, when compared to B cells and 
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neutrophils (Fig. 6G). In contrast, only very low levels of genes within the B cell-related clusters 
were detected in any of the Mφ data sets including those derived from pro-B cells (supplementary 
data Fig. 7.5A-C), and their expression levels were consistent with our post-sort purity analysis 
data, which indicated the presence of low levels of contaminating B cells (0-10%) in some Mφ 
samples (Supplementary Fig. 7.2). Importantly genes in clusters C55 and C71 were expressed 
highly by both types of inflammation-induced Mφs including pB-Mφinflam as well as mo-Mφinflam in 
comparison to other Mφs populations (Fig. Supplementary 7.4F), while embryonic and pro-B cell-
derived Mφs from naïve peritoneum (MφTR-naïve and pB-MφTR-naïve) and following inflammation 
(MφTR-inflam and pB-MφTR-inflam) characteristically expressed genes included in clusters C6, C36 and 
C40 (Supplementary 7.4G). Hence transcriptome analysis also reveals the plasticity of the pro-B-
derived Mφ precursors that give rise to two distinct subsets of Mφs with vastly contrasting 
phenotypes during homeostasis (pB-MφTR-naïve) and inflammation (pB-Mφinflam). Genes in all of the 
mononuclear phagocyte-related clusters were expressed highly in pB-Mφs at similar levels to 
those expressed by embryonic/monocyte-derived Mφs counterparts. No clusters were identified 
which contained unique genes expressed highly in pB-Mφs alone. Similarly, no genes were 
identified, which were expressed highly in embryonic/monocyte-derived Mφs, but not in pB-Mφs. 
Together these data suggest that despite the distinct origin of the pro-B cell-derived Mφs, they 
share very similar transcriptional and therefore predicted phenotypic characteristics with ‘classical’ 
Mφ populations, i.e. embryonic/monocyte-derived Mφs.  
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DISCUSSION 
Our study highlights the developmental plasticity of immature B cells and their role as an additional 
source of Mφs in vivo. Here we provide evidence of a subset of early pro-B cells with non-
rearranged BCR that differentiate into Mφs during homeostasis and inflammation. In this work we 
used a combination of B cell-specific reporter mice including Mb1-iCre/Rosa26-YFP, Cd19-
Cre/Rosa26-YFP, and Rag2-/-/Mb1-iCre/Rosa26-YFP, which enabled fate mapping studies to 
establish that a proportion of tissue-resident Mφs in serous cavities and intestine are derived from 
a novel sub-population of non-rearranged early pro-B cells co-expressing B cell and myeloid 
markers. 
 
These findings are fundamentally distinct from earlier reports, which demonstrated myeloid lineage 
switch occurring in early lymphoid progenitors in vitro(12, 36, 37) as well as B cell-to-Mφ 
differentiation using enforced C/EBPα expression(15, 16, 38). Indeed, bi-potential progenitors that 
give rise to Mφs have been reported in postnatal bone marrow(39). However, these cells are 
different to pB-Mϕprecursors reported here, as they are CD45R-CD19+CD127+CD11b-Gr1- and D-J+. 
Moreover, AA4.1+B200-Mac1-Ly6A+ bi-potential progenitors in foetal liver(12) and adult bone 
marrow early progenitors with lymphoid and myeloid potential (EPLMs) expressing B220, c-Kit, IL-
7Rα (CD127), Flt3 (CD135) and CD93, but not CD19 and NK1.1(10), demonstrate both lymphoid 
and myeloid potential in vitro. While the above reports and other studies used primarily artificial 
experimental systems(17-19) we demonstrate a novel bi-phenotypic population within early pro-B 
cell that contributes significantly to Mφs populations in vivo, representing a normal facet of 
haematopoiesis.  
 
Although YFP expression was detected in some CLPs, very few mature T cells (<0.5%) and 
indeed thymic progenitors (~0.15%) expressed YFP. We suspect that the vast majority of YFP+ 
CLPs (Lin-IL7Rα+Sca-1+c-Kit+) are committed toward a B cell differentiation pathway as YFP 
expression within these CLPs is enabled by Cd79a (Mb-1) promoter activation driven, in turn, by 
E2A and EBF transcription factors, which initiate early B cell lymphopoiesis(40). Indeed, the 
complete absence of eYFP expression on mature myeloid cells after transfer of Mb-1iCre/Rosa26-
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YFP LMPPs into alympoid recipients would strongly argue that in the generation of graft-derived 
myeloid cells in this model does not originate from a LMPP progenitor. Therefore, these 
progenitors are unlikely to account for selective YFP expression in tissue-resident Mφ populations 
in the peritoneum, pleural cavity and intestine. This assertion is reinforced by the lack of YFP+ Mϕs 
in irradiated mice receiving YFP+ CLPs.  
 
The molecular signals that enable a myeloid fate in the subset of early pro-B cells described here 
remains to be elucidated. However, it’s likely that the demand for Mφs in tissues generates these 
signals. Indeed, this became evident during zymosan-induced peritonitis where local inflammatory 
factors triggered the expansion of bone marrow pB-Mφprecursors, which egressed into blood and 
accumulated in the peritoneum where they differentiated into inflammatory pro-B cell-derived Mφs 
(pB-Mφinflam).  While these temporal changes are certainly only correlative, these data suggest that 
not only do bone marrow pB-Mφprecursors seed the peritoneal and pleural cavity as well as the 
gastrointestinal system during homeostasis, but that these circulating blood precursors enter the 
sites of infection/injury and generate Mφ during inflammation. Notably, despite their different 
origins, pB-Mφs are transcriptomically similar to embryonic Mφs during steady state/homeostasis, 
but are phenotypically distinct from those generated by pB-Mφprecursors during inflammation thereby 
emphasizes the functional plasticity of pB-Mφprecursors, which is likely to be determined by the tissue 
environment and inflammatory signals they receive.  
 
Consistent with the lack of IL7 receptor on pB-Mφprecursors, in vitro assays revealed the propensity of 
these cells to differentiate down a myeloid lineage. Indeed, reconstitution of tissue-resident Mφs in 
lethally irradiated mice was observed by adoptively transferring these early pro-B cells, but not 
LMPPs or CLPs. In terms of the origin of these cells, bone marrow pB-Mφprecursors as well as the 
CD19+YFP+V-DJ- intermediate Mφs in the peritoneum express CD19 as extensively verified by a 
number of methods including single cell profiling. CD19 expression on the cells, which is strictly 
controlled by the transcription factor PAX5, suggests their close developmental relationship with B 
cells (41). These data indicate a hematopoietic progenitor present within bone marrow Fraction B 
that evidence Mφs development potentials and co-express certain markers of both lymphoid and 
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myeloid lineages. It must be emphasized that these precursors lack detectable immunoglobulin 
rearrangements and they are unable to generate B lineage cells in B cell-promoting culture 
conditions. In which case, its likely that these bi-phenotypic macrophage precursors are committed 
to the myeloid lineage but express transiently some B lineage markers.  We believe, that this 
mechanism is an additional source of tissue Mφs and is an intrinsic part of normal haematopoiesis 
in vivo. In summary, the discovery of novel Mφ subsets arising from pro-B cells reveals an 
alternative source of Mφs during homeostasis and inflammation. These data significantly advance 
and expand our understanding of Mφ biology and haematopoiesis, the plasticity of hematopoietic 
precursors and the heterogeneity of Mφ subsets. 
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MATERIALS AND METHODS 
Animals 
C57BL/6 (Harlan), B6.129P2-Cd19<tm1(cre)Cgn/J, B6.Cg-Tg(Cr2-cre)3Cgn/J (Jackson 
Laboratories), Rosa26-YFP (kindly provided by Ulla Dennehy, London, UK), B6.CD45.1 (kindly 
provided by Prof B. Stockinger, London, UK) and B6.Mb1-iCre (kindly provided by Prof M. Reth, 
Freiburg, Germany) mice (male 6-8 weeks old) were housed and breed in pathogen free 
conditions. All experiments were performed in compliance with United Kingdom Home Office 
regulations. 
 
Peritonitis and resident phagocytic cell labelling 
Self-resolving peritonitis was induced by intraperitoneal (i.p) injection of sterile zymosan A, from 
Saccharamyces  cerevisiae (Sigma) solution in PBS at a dose of 0.1 mg/mouse. Peritoneal cells 
were collected from naïve animals and 4, 16/24, 48 and 72h post-inflammation. For labelling of 
resident peritoneal phagocytes 0.5 ml of 0.5 μM PKH26PCL (PKH-Red) fluorescent cell linker 
(Sigma) solution in diluent B (Sigma) was injected IP prior induction of peritonitis accordingly to 
manufacturer’s instructions.   
 
Bone marrow adoptive transfer/ 
C57BL/6 mice (CD45.2) were lethally irradiated with single dose of 950 RAD and reconstituted with 
2.5x106 donor bone marrow cells. Each mouse received i.v. injection of mixed population of  
FACS-purified YFP+ bone marrow B cells from Mb1-iCre/Rosa26-YFP mice and total CD45.1+ 
bone marrow cells from congenic wild-type strain at 1:10 ratio. Total early pro-B cells 
(YFP+B220+CD19+CD43+CD24+BP-1-) containing biphenotypic YFP+CD16/32++CD11b++ pB-
Mφprecursors or mature bone marrow B cells (YFP+B220highCD19+CD43-CD24low) were analysed for 
their potential to reconstitute tissue Mφs, while CD45.1+ total bone marrow cells were injected into 
animals to improve the survival rates following lethal irradiation. Haematopoietic reconstitution was 
analysed by flow cytometry analysis in peritoneum and spleen at 2, 4 and 6 weeks following 
irradiation and adoptive transfer.  
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Flow cytometry and cell sorting 
Flow cytometry and cell sorting were performed on LSR-II/LSR-Fortessa and FACSAria (BD 
Biosciences), respectively. For flow cytometry analysis 0.5-1x106 of freshly isolated cells 
reconstituted in FACS buffer and incubated with Fc-Blocker (AbD Serotec) were stained in final 
volume of 50 μl for 20-30 min and then washed 3 times with 150 μl of FACS buffer. For FACS 
sorting cells were re-suspended at 10x106 cells /40 μl of FACS buffer. Following antibodies were 
used: CD11b-PerCP-Cy5.5/V450/Alexa-700, CD19-Alexa Fluor 700/PE, CD23-PE-Cy7, CD21-
APC, IgM-PE/PE-Cy7/Biotin, Gr1-APC/PE, B220-Alexa-700/Horizon-V500, BP-1(Ly-51)-Biotin, 
CD24(HSA)-PE-Cy7, Streptavidin-APC/Horizon-V450/Horizon-V500 from BD Pharmingen; CD19-
FITC, B220-RPE, F4/80-APC from AbD Serotec; MHC-II-PE/FITC/Alexa-700, F4/80-APC/PE-
Cy7/PerCP-Cy5.5, CD115-PE/APC, CD16/32(FcγR)-PerCP-Cy5.5, CD34-Alexa Fluor 700 and 
CD127(IL7Ra)-PE-Cy7 from eBioscience; biotyinilated Abs for lineage markers were purchased 
from eBiosciences: CD3(17A2), CD4(GK1.5), CD8(53-6.7), CD19(1D3), B220(RA3-6B2), IgM(R6-
60.2), Gr1(RB6-8C5), CD11b(M1/70), Ter119(TER119), NK1.1.(PK136); Live/Dead viability dye 
from Invitrogen. Flow cytometry data analysis was performed with FlowJo vX.0.7 software (Tree 
Star) using fluorescence minus one control samples as reference for setting gates.  
 
Statistical analysis 
Statistical evaluation of data was performed in GraphPad Prism (GraphPad Software) by an 
unpaired t-test in case of two groups and one-way ANOVA using Bonferroni post-test. A P-value of 
less than 0.05 was considered statistically significant (*P < 0.05, **P < 0.01, ***P < 0.001). 
Statistical analysis of BCR sequencing and microarray data was performed using R project 
software. 
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For BCR re-arrangements assessment, detection of B cell- and Mφ-specific mRNA transcripts 
were amplified by RT-PCR, Microarray analysis and Hematopoietic cell isolation please see 
Supplementary materials and methods.  
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Figure 1. Mφs with a potential B cell origin detected in Mb1-iCre/Rosa26R-YFP reporter 
mice. a, Flow cytometric analysis of wild type C57BL6 mice showing CD19 expression on 
peritoneal CD11b++F4/80++ Mφs. (b) Equivalent analysis of Mb1-iCre/Rosa26-YFP mice showing 
YFP expression pattern in Mφs from various tissues. Representative data shown for n=10 
experiments carried out on naïve animals. 
Figure 2. YFP+ Mφs in Mb1-iCre/Rosa26R-YFP mice do not arise form mature B cells. a, 
ImageStream analysis of nave murine peritoneum. Dot-plots showing single focused cells in 
CD11b++F4/80++ Mφ gate identifying 3 Mφ populations: CD19-YFP-, CD19-YFP+ and CD19+YFP+; 
non-Mφ (CD11b+/-F4/80-) compartment containing CD19+YFP+ B cells. b, Representative images 
of CD11b++F4/80++ Mφ populations and B cells are shown. While confirming the presence of Mφs 
co-expressing CD11b, F4/80, YFP and CD19, ImageStream reveals a substantial amount of 
doublets occur within rare population of CD19+YFP+ Mφs; the frequency of single bi-phenotypic 
cells within CD19+YFP+ Mφ gate constitute ~16.74 % (see table). c, Detection of V-DJ re-
arrangements and expression B cell- and Mφ-specific genes in single and multiple cells purified by 
FACS. At least 45 single and multiple (20/10/5) cells of each type, including peritoneal B-1/B-2 B 
cells, and CD11b++F4/80++ Mφ populations: CD19-YFP-, CD19-YFP+ and CD19+YFP+, were 
analysed for presence of V-DJ re-arrangements in genomic DNA, B cell-specific Cd79b transcript 
and Mφ-specific  Emr1 transcript. The frequency of V-DJ+ reactions shown at  the bottom of the 
graph demonstrating that despite co-expression of Cd79b and Emr1 in intermediate CD19+YFP+ 
Mφs low number (15 out of 45 versus 32 out of 45 ) of V-DJ+ reactions compared to B cells is 
detected on single cell level. The number of V-DJ+ reactions increase (38 out of 45)  to B cell 
levels, when multiple cells (20/10/5) of CD19+YFP+ Mφs are analysed per reaction, suggesting 
contamination by B cells.    
Figure 3. Evaluation of B cell-specific reporter mice point toward early pro-B cell origin of 
YFP+ Mφs. Cells and tissues from Mb1-iCre/Rosa26-YFP mice (Mb1-iCre), CD19-Cre/Rosa26-
YFP mice (CD19-Cre), Rag2-/-/Mb1-iCre/Rosa26-YFP mice (Rag2-/-/ Mb1-iCre), Cr2-Cre/Rosa26-
YFP mice (Cr2-Cre) and Rosa26-YFP mice were collected and analysed by flow cytometry. a, 
Representative dot-plots showing induction of YFP expression at later B cell bone marrow 
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developmental stages in CD19-Cre/Rosa26-YFP mice (CD19-Cre) as compared to Mb1-
iCre/Rosa26-YFP mice (Mb1-iCre). For gating strategy see Supplementary Fig. 4.1a & b, 
Representative dot-plots showing YFP expression in peritoneal CD19+ B cells and CD11b++F4/80++ 
Mφs in mouse strains above.  
 
Figure 4. Bi-phenotypic populations of CD19+B220+CD43+YFP+CD16/32++CD11b+ with B-
lymphoid and myeloid characteristics identified in bone marrow (a) and blood (b). These cells will 
be further referred to as pB-Mφprecursors. c, Quantification of 
CD19+B220+CD43+YFP+CD16/32++CD11b+ pB-Mφprecursors in early B cell bone marrow fractions. 
Values expressed in absolute numbers of cells per one limb.  
 
Figure 5. YFP+ Mφs are generated from bi-phenotypic B220+CD43+CD19+ YFP+CD16/32++ 
CD11b+ pro-B cell-derived precursors in response to inflammation. Inflammation was induced 
by intraperitoneal injection of 0.1 mg zymosan. Tissues were collected at various time-points post 
peritonitis induction and anlysed by flow cytometry. a, Gating strategy showing identification of 
B220+-CD19+ B cells, B220+-CD19+CD16/32++CD11b++ peritoneal pB-Mφ precursors, YFP-B220-CD19-
F4/80++CD16/32++CD11b++ Mφs and YFP+B220-CD19-F4/80++CD16/32++CD11b++ pB-Mφs in naïve 
peritoneum. b, Dot plots showing B220+-CD19+ B peritoneal compartment with increased 
proportion of CD16/32++CD11b++ pB-Mφ precursors and B220-CD19- compartment with reduced 
frequency of F4/80++CD11b++ Mφs at 4 hours post peritonitis induction. c, Temporal profiles of 
peritoneal Mφs, pB-Mφs  and peritoneal pB-Mφ precursors during inflammation with d showing cell 
surface markers for the cells over time. Panels e and f show the temporal profiles of pB-Mφ precursors  
in bone marrow and peripheral blood, respectively, during inflammation. Values expressed as 
proportion form total bone marrow or blood cells. Statistical evaluation was performed by one-way 
ANOVA using Bonferroni post-test (*P < 0.05, **P < 0.01, ***P < 0.001). 
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Figure 6. In vitro assays for pro-B cell-derived precursors differentiation. (a) shows results of 
in vitro assay where single cell populations were cultured for 10-14 days in media supporting either 
myeloid or lymphoid growth with results shown as numbers of events bearing either lymphoid or 
myeloid phenotype in respective media as per materials/methods. b, FACS-purified peritoneal 
Mφs, B cells and pB-Mφ precursors from 4 hour peritonitis were cultured with/without M-CSF/GM-CSF 
and analysed by cell morphology using Rapid-Romanowsky stain and α-CD19, α-F4/80 and DAPI 
labelling. Scale bars, 20 µm. h, Cell size was quantified using ImageJ. Statistical evaluation was 
performed by one-way ANOVA using Bonferroni post-test (*P < 0.05, **P < 0.01, ***P < 0.001). ND 
= not detected. 
 
Figure 7. pB-Mφprecursors within early pro-B cell bone marrow fraction reconstitute peritoneal 
Mφs in lethally irradiated mice. FACS-purified early pro-B cells containing 
YFP+CD16/32++CD11b bi-phenotypic pB-Mφprecursors and mature B cells (control) from bone 
marrow of Mb1- iCre/Rosa26-YFP mice (see supplementary Fig. 6.1) were mixed in ratio 1:10 
with total bone marrow cells from congenic CD45.1 donor mice and injected i.v. into lethally 
irradiated (950 RAD) wild type mice. Haematopoietic reconstitution was assessed in peritoneum 
and spleen at 6 weeks post injection of donor bone marrow cells. a Representative plots showing 
tracing markers expression on peritoneal cell populations of naïve CD45.1 and Mb1-iCre/Rosa26-
YFP mice and b engraftment of donor CD45.1+ (all lineages) and YFP+ (early pro-B/mature B) 
cells in peritoneum of lethally irradiated mice. c Haematopoietic lineages reconstitution analysis in 
spleen showing engraftment of CD45.1+ progenitors in B, T and myeloid compartment, while YFP+ 
early pro-B cells exclusively contribute to reconstitution of B cell lineage and do not differentiate 
into myeloid or T cells. d Lin-IL7Rα+Sca-1++c-Kit++ CLPs containing YFP+ CLPs was mixed with total 
bone marrow cells from congenic CD45.1 donor mice and injected into irradiated wild type mice 
and engraftment determined in the peritoneal B cell and myeloid compartments as well as spleen.  
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Figure 8. Pro-B cell-derived Mφs possess transcriptome profile similar to their embryonic 
and monocyte-derived counterparts. a, Inflammation was induced in Mb-1.iCre/Rosa26-YFP 
mice by intraperitoneal injection of 0.1 mg zymosan. Flow cytometry revealing (P1) YFP- 
embryonic MφsTR-naive and (P2) YFP+ pro-B cell-derived pB-MφsTR-naïve in naïve peritoneum. PHK-
Red injected  prior to peritonitis labels resident phagocytes and reveals four CD11b++F4/80++ Mφ 
subsets at resolution (72 hours): (P3) YFP- resident (embryonic, YFP-PKH+ [MφsTR-inflam]) and (P4) 
YFP- inflammation-induced Mφs (monocyte-derived ,YFP-PKH- [mo-Mφsinflam]) along with two 
groups of pro-B cell-derived YFP+ Mφs generated during homeostasis namely (P5) resident pB-
Mφs (YFP+PKH+  [pB-MφsTR-inflam]) and (P6) inflammation-induced pB-Mφs (YFP+PKH- [pB-
Mφsinflam]). The software tool Biolayout Express3D was used for the visualization and analysis of 
Illumina Mus musculus 6v2 microarray data, which were variance stabilized (VST) and robust 
spline normalized (RSN) using the lumi R/BioConductor package. Correlation networks, sample 
comparison and identification of co-expression modules was performed in Biolayout Express3D for 
30 data sets (n=3 per group). b, Sample similarity analysis diagram showing cell type-specific 
clustering of datasets. Analysis was performed using Person correlation threshold of r ≥ 0.97 and 
MCL clustering algorithm with inflation value of 3.0. Individual clusters of nodes (samples) were 
arbitrarily assigned a colour. c, Network graph generated using Person correlation threshold of r ≥ 
0.95 and MCL clustering algorithm with inflation value of 1.7 is showing clusters of genes 
correlating in their expression profiles and includes clusters of genes with similar function and/or 
genes with cell-specific expression pattern. Table S1 provides the content of each of these 
clusters.  
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Supplementary Figure 1.1 
Supplementary Figure 1.1. Gating strategies for flow cytometric identifications of tissue-
resident Mφs. a, Tissue-resident Mφs were discriminated from cell debris by size (FSC) and 
granularity (SSC), followed by cell doublets exclusion using Height (FSC-H/SCC-H), Width 
(FSC-W) and Area (SCC-A) parameters, and then identified within live cell gate as CD11b++
(brain and liver) or as CD11b++F4/80++(intestine) cells within CD45+CD19- population. Splenic 
Mφs were identified as CD3-CD19-MHC-II+ cells, which were CD11b+CD11c-(R3) and F4/80+(not 
shown), while peritoneal and pleural cavity Mφs were CD19-CD11c-CD11b++F4/80++. 
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Supplementary Figure 1.2 
Peripheral blood	  
Supplementary Figure 1.2 Analysis of Mb1-iCre/Rosa26-YFP mice for YFP expression within cells 
of various organs including (a) peripheral blood B and T cells as well as monocytes and neutrophils. 
Analysis of (b) bone marrow hematopoietic precursors revealed some YFP expression in uncommitted 
common lymphoid progenitors (CLP) only while (c) shows YFP expression in thymus. 
 
 
Supplementary Figure 1.3  
Supplementary Figure 1.3. Gating strategies for flow cytometric identification of 
peripheral blood cell populations. a, Blood cells were discriminated from cell debris by size 
(FSC) and granularity (SSC), followed by cell doublets exclusion using Height (FSC-H/SCC-H), 
Width (FSC-W) and Area(SCC-A) parameters. B cells were identified within B220+CD19+ gate, 
T cells as CD3+ within B220-CD19- gate, while neutrophils were CD115-Gr1++  and monocytes 
were CD115+Gr1+/- cells within B220-CD19-CD3- gate.  
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Supplementary Figure 1.4. Gating strategies for flow cytometric identification of 
hematopoietic progenitors in bone marrow and T cell progenitors in thymus. a, Bone 
marrow/thymus  cells were discriminated from cell debris by size (FSC) and granularity (SSC), 
followed by cell doublets exclusion using Height (FSC-H/SCC-H), Width (FSC-W/SCC-W) 
parameters. b, Sca-1++c-Kit++ multi-lineage progenitors (MLP) and Sca-1+c-Kit+ common 
lymphoid progenitors (CLP) were identified within Lin-IL7Rα- and Lin-IL7Rα+ bone marrow 
fractions respectively. c, Sca-1-c-Kit++ total myeloid progenitors (MP) were identified within Lin-
IL7Rα- bone marrow fraction and were comprised of three populations: CD34+/-CD16/32+ 
common myeloid progenitor (CMP), CD34+CD16/32++ granulocyte/macrophage progenitor 
(GMP) and CD34-CD16/32- megakaryocyte/erythrocyte progenitor. d, CD4-CD8- (DN) Early 
Thymic progenitors (ETP) were identified within Lin- fraction of thymic cells, while immature 
thymocytes CD4+CD8+ and mature T cells were either CD4+ or CD8+. Lin  markers for MLPs and 
CLPs included CD3, CD4, CD8, B220, CD11b, Gr1, TER119; for MPs - CD3, CD4, CD8, CD19, 
B220, IgM, CD11b, Gr1, TER119; for ETPs - CD19, B220, CD11b, Gr1, NK1.1, TER119.  
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Supplementary Figure 2 
Supplementary Figure  2. Phagocytosis of YFP+ B cells by Mφs does not result in 
generation of YFP+ Mφs. a, Immunoﬂuorescent	   microscopy	   on	   FACS-­‐puriﬁed	   peritoneal	   cell	  
popula9ons.	   b, Flow cytometric analysis of splenic YFP+ CD19+ B cells following FACS-
purification was carried out immediately after purification and at 5 and 20 hours after culturing in 
RPMI media supplemented with 5 % FBS, 1000 U/ml penicillin, 1000 µg/ml streptomycin and 2 
mM L-glutamine. Upon culturing without stimulation splenic B cells spontaneously undergo 
apoptosis as determined by Annexin V and 7-AAD staining. Importantly, after 20 hours the loss 
of the YFP signal from FACS-purified YFP+CD19+ splenic B cells correlated with low forward 
scatter and double labelling for Annexin V and 7-AAD, which are characteristic of advanced 
apoptosis. c, Dot-plots showing CD11b++F4/80++ Mφ pre-sort populations in peritoneal washout: 
YFP+ Mφs (green), YFP- Mφs (red) and very few events showing as YFP low (blue); post-sort 
purity assessment of YFP- and YFP+ Mφs. FACS-purified peritoneal YFP- Mφs were co-
incubated with 5 or 20 hours-aged splenic YFP+CD19+ B cells for 1 hour and phagocytosis was 
analysed by (d) microscopy where nuclei were visualized by DAPI in blue, α-F4/80 staining in 
red and α-GFP(YFP) staining highlights YFP+ B cells and YFP+ Mφs in green. Yellow arrow 
heads highlight phagocytised B cells, as determined by dense DAPI labelling of apoptotic B cell 
nuclei contrasting with larger Mφ nuclei revealing condensed and relaxed chromatin structures. 
e, Flow cytometric analysis following co-culturing of YFP- Mφs with aged splenic B cells 
revealed only a minor population of Mφs (in blue gate) with increased YFP signal. Histogram 
showing YFP signal expressed as mean fluorescence intensity (MFI) confirms that population of 
YFP- Mφs that have phagocytised YFP+ B cells doesn’t gain YFP signal comparable to YFP 
signal detected in YFP+ Mφs of Mb1-iCre/Rosa26-YFP mice. 
Supplementary Figure 3.1 
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Supplementary Figure 3.1 ImageStream analysis of peritoneal bi-phenotypic YFP+CD19+ 
Mφs in Mb1-iCre/Rosa26-YFP mice. a, Single cells were discriminated from doublets by 
Aspect ratio and Area parameters. Mφs were identified as CD11b++F4/80++ cells (Mac) within 
single focused cell gate while  B cells are YFP+CD19+ population within non-Mφ gate. b, Dot 
plot showing increased frequency of YFP+CD19+ population in the CD11b++F4/80++ Mφ gate, 
when gated on focused doublets. c, Representative images of cell populations gated as above 
confirming CD19 expression on a sub-population of YFP+ Mφs, but showing that Aspect ratio 
and Area parameters do not allow to exclude all cell clusters and specifically those  that have 
width to heights ratio close to 1, as shown for YFP+CD19+ Mφ population clusters in singlets 
gate.  
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Supplementary Figure 4.1 
a 
Supplementary Figure 4.1 Gating strategy for flow cytometric identification of B cell 
development stages in bone marrow. a, Bone marrow cells were discriminated from cell 
debris by size (FSC) and granularity (SSC), followed by cell doublets exclusion using Heights 
(FSC-H/SCC-H), Width (FSC-W/SCC-W) parameters. Early B220+CD43+ and late B220+CD43- 
B cell development stages were identified within CD11b-CD3- gate. Early B cells were separated 
into fractions A, B, C and C’ using CD24/HSA and PB-1/Ly-51 antigens: with fraction A being 
pre-pro-B cells, fraction B and C – pro-B cells and fraction C’ – pre-B cells. B220+CD43- B cells 
comprised of fractions D (pro-B), E (new-B) and F (mature B) discriminated by IgM and IgD 
expression. b, Despite CD19 being expressed on the majority of fraction B/pro-B cells, YFP 
levels in this early B cell subset of CD19-Cre/Rosa26-YFP mice (CD19-Cre) are very low 
compared to those detected in Mb1-iCre/Rosa26-YFP mice (Mb1-iCre). 
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Supplementary Figure 4.2 
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Supplementary Figure 4.2 High CD16/32 and CD11b expression intrinsic to myeloid cells. 
a,  Flow cytometry analysis of bone marrow and peripheral blood cell populations revealed high 
levels of CD16/32 and CD11b on myeloid cells: Gr1++CD115- granulocytes and Gr1+CD115+ 
monocytes in contrast to B220+CD19+ B cells.    
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Supplementary Figure 4.3 Cell surface characteristics of bi-phenotypic pB-Mφprecursors in 
naïve bone marrow and blood. Cells and tissues from Mb1-iCre/Rosa26-YFP mice were 
collected and analysed by flow cytometry. a, Bi-phenotypic pB-Mφprecursors with B cell and 
myeloid characteristics namely CD19+B220+CD43+YFP+CD16/32++CD11b+ were identified in 
bone marrow and blood. b, Expression pattern of selected cell surface markers on pB-
Mφprecursors from naive bone marrow and blood with c showing the expression on IL7Ra during 
the early phases of B cell development. 
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Supplementary Figure 5.2. Morphological changes  in pB-Mφprecursors and Mφs during in 
vitro cell culturing. FACS-purified Mφs, peritoneal B cells and peritoneal pB-Mφprecursors from 4 
hour peritonitis were cultured on poly-L-lysine-coated coverslips with/without M-CSF for 1, 3, 
and 6 days. a, Rapid-Romanowsky stain revealed typical morphology of B cells for pB-
Mφprecursors characterized by high nuclear-cytoplasmic ratio and small cell size, while elongated/
spindle-shaped Mφs had significantly lower nuclear-cytoplasmic ratio and greater cell size at 
day 1. Upon culturing  in presence of 10ng/ml  M-CSF majority of pB-Mφprecursors acquired 
morphology characteristic for Mφs, while B cells and pB-Mφprecursors without M-CSF remained  
small and round cells. Scale bars, 20 µm. 
Supplementary Figure 6.1 
Supplementary Figure 6.1. Gating strategy for isolation of early pro-B and mature B cells from 
bone marrow of Mb1-iCre/Rosa26R-YFP mice. Mature B cells (YFP+B220highCD19+CD43-CD24low) and 
early pro-B /Fr. B cells (YFP+B220+CD19+CD43+CD24+BP-1-) from bone marrow of Mb1-iCre/Rosa26-
YFP mice were FACS-purified as shown and injected into lethally irradiated mice to trace the 
reconstitution of tissue Mφ populations by bi-phenotypic YFP+CD16/32++CD11b++ pB-Mφprecursors within 
early pro-B cell fraction.  
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Supplementary Figure 6.2. YFP+CD16/32++CD11b pB-Mφprecursors within early pro-B cell bone marrow 
fraction reconstitute peritoneal Mφs in lethally irradiated mice. Gating strategies identifying lymphoid 
and myeloid cell populations in (A) peritoneum and (B) spleen. FACS-purified early pro-B cells containing a 
bi-phenotypic pB-Mφprecursors and mature B cells (control) from bone marrow of Mb1-iCre/Rosa26-YFP mice 
(see suppl. Fig. 6.1) were mixed in ratio 1:10 with total bone marrow cells from congenic CD45.1 donor mice 
and injected i.v. into lethally irradiated (9.5 Gy) wild type mice. Haematopoietic reconstitution was assessed 
in peritoneum and spleen at 2 and 4 weeks post injection of donor bone marrow cells. (C) Representative 
plots showing engraftment of donor CD45.1+ (all lineages) and YFP+ (early pro-B/mature B) cells in the 
peritoneum of lethally irradiated mice at 2 and 4 weeks post adoptive cell transfer.  
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Supplementary Figure 7.1. PKH-Red labelling distinguishes between resident and inflammation-
induced populations of peritoneal Mφs. To label resident peritoneal Mφs in contrast to infiltrating monocytes 
and inflammation-induced Mφs, phagocytic dye PKH-Red was injected i.p. 2 hours prior to zymosan 
administration. a, Gating strategy for identification of peritoneal  Mφs. b, Peritoneal and peripheral blood 
leukocyte populations were analysed by flow cytometry. CD11b++F4/80++ peritoneal Mφs revealed bright and 
homogenous labelling after 2 hours post PKH-Red injection being a result of phagocytic ingestion of the dye, 
while no CD3-CD19-Gr1-/+CD115+ blood monocytes were labelled by PKH-Red at any time. Animals that 
received PKH-Red and zymosan (PKH + Zym) i.p. revealed PKH-Red+ (resident) and PKH-Red- (inflammation-
induced/monocyte-derived) populations within CD11b++F4/80++ Mφ gate. c-d, Due to their phagocytic ability 
CD19+ B cells acquire some PKH-Red signal, which is however significantly lower than PKH-Red labelling of 
resident Mφs (b, c), including YFP+ Mφs present in naïve cavity and at 72 hours (d). This allows discrimination 
between PKH+ pB-Mφs present in naïve peritoneum and PKH-/low pB-Mφsinflam triggered from pro-B cells (PKH-
Red-/low) by inflammation detected by 72 hours of zymosan peritonitis in Mb-1.iCre/Rosa26-YFP mice (d).  
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Supplementary Figure 7.2 
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Cell type MφTR-naïve  MφTR-inflam mo-Mφinflam pB-MφTR-naïve  pB-MφTR-inflam pB-Mφinflam  
Replicate # 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 
B cells, % 0.78 0.42 3.72 0.43 0.00 0.64 0.00 0.00 0.20 7.04 3.54 3.46 1.39 0.00 3.12 6.9 10.1 3.1 
Post-sort purity assessment : CD19+ B cell content in Mφ samples 	  
Supplementary Figure 7.2. Gating strategy for isolation of Mφ and B cell sub-sets from 
Mb1-iCre/Rosa26R-YFP mice and post-sort purity assessment.  a,  CD19+ B cells and 
CD11bhighF4/80high peritoneal Mφs identified among live single cells demonstrate YFP, F4/80 
and CD11b expression levels characteristic for each cell type, i.e. high YFP, low/no F4/80 and 
no/intermediate CD11b expression on B cells; high F4/80 and CD11b on all Mφs with fraction of 
Mφ population expressing YFP. b-c,  Gating strategies for FACS-purification of peritoneal Mφ 
populations and B cells from naïve  peritoneum (b) and peritoneum at 72 hours post zymosan 
peritonitis induction (c). d, Mφ populations (n=3 per group) used for transcriptomic analysis 
were subjected to post-sort purity assessment. The content of contaminating B cells (YFP
+CD19+) in FACS-purified Mφ samples, expressed in % from total Mφ sample. 
Supplementary Figure 7.3 
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Supplementary Figure 7.3. Low variability across biological replicates of transcriptomic 
samlpes. Probe labelling and hybridization were performed using an Illumina Mus musculus 
6v2 microarray (n=3 biological replicates). Array probe summaries were calculated in 
BeadStudio (Illumina) and subsequently normalized by a variance stabilising transformation 
(VST) and robust spline normalisation (RSN) using the lumi R/BioConductor package. a-b, Box 
plots of un-normalized (a) and normalized (b) expression data showing low variation within each 
sample group (n=3). 
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Supplementary Figure 7.4. Transcriptome analysis of pro-B cell-derived Mφs: expression 
profile of selected genes and gene clusters. The software tool Biolayout Express3D was used 
for the visualization and analysis of Illumina Mus musculus 6v2 microarray data, which were 
variance stabilized (VST) and robust spline normalized (RSN) using the lumi R/BioConductor 
package. Full probeset-to-probeset Pearson correlation matrix was calculated in Biolayout 
Express3D for each transcript represented on the array across the 30 samples using a 
correlation threshold of r ≥ 0.95; MCL clustering algorithm with inflation value of 1.7 was used to 
generate gene clusters with similar functions or cell-specific activities. Expression profile of 
selected genes (b) or gene clusters (a, c-g) across all samples showing expression levels in 
pro-B cell-derived Mφs (blue rectangle) and embryonic/monocyte-derived Mφs (red rectangle). 
Mean expression levels of probe sets in monocyte-related cluster C7 and Neutrophil-related 
cluster C1 (a); Gene expression level of selected monocyte-related gene Ccl2 and neutrophil-
related Csf3r gene (b). Mean expression profiles of genes within cell-cycle-related gene cluster 
C16. (c); ribosomal and transcription-related gene clusters C20 and C24 (d) expressed highly 
by almost all cell populations except neutrophils; cluster C72 containing MHC class II genes 
expressed highly by B cells and both populations of inflammation-induced Mφs (pB-Mφinflam/
mo-Mφinflam) (e).	   Genes highly expressed in inflammation-induced Mφs (pB-Mφinflam/mo-
Mφinflam) in comparison to the other macrophage populations were found in clusters C55 and 
C71 (f), while clusters C6, C36 and C40 included genes characteristically expressed by tissue-
resident Mφs from naïve (pB-MφTR-naïve/MφTR-naïve) and inflamed (pB-MφTR-inflam/MφTR-inflam) 
peritoneum (g). 
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Expression profile of selected genes or gene clusters across all 30 datasets plotted in a-c  
showing expression levels for pro-B cell-derived Mφs (blue rectangle) and embryonic/monocyte-derived 
 Mφs (red rectangle). Mean expression levels of probe sets in B cell-related clusters C2. and C4. (a) and 
 Monocyte/Mφ-related clusters C5. C17, C50 (c); Gene expression level of selected B cell-related genes 
 IgH-V11, Sox5 and Cd19 (b) and Monocyte/Mφ-related genes Csf1r and Lyz1 (d). No clusters were  
identified, which contained genes which were expressed highly in pro-B cell-derived Mφs alone.  
 
Supplementary Figure 7.5 
Supplementary data, Table S1 
 
1) Spleen 
 
 Day 7 
% CD45.2 
 
% eYFP in CD45.2 
Day 14 
% CD45.2 
 
%eYFP in CD45.2 
CD4 T cells 0.18 ± 0.14 0 5.03 ± 0.90 0 
CD8 T cells 0.15 ± 0.08 0 2.59 ± 0.79 0 
γδ T cells 0.12 ± 0.22 0 0.63 ± 0.31 0 
NK cells 4.91 ± 3.12 0.80 ± 0.83 4.28 ± 2.01 0.38 ± 0.33 
imm. B cells 29.94 ± 5.81 28.78 ± 4.57 13.95 ± 3.27 13.46 ± 2.84 
T1 B cells 5.86 ± 1.46 5.59 ± 1.75 18.68 ± 3.68 18.21 ± 3.87 
T2 B cells 2.98 ± 1.11 2.71 ± 1.13 7.56 ± 1.09 7.45 ± 1.46 
T3 B cells 0.77 ± 0.53 0.57 ± 0.36 8.92 ± 0.92 8.20 ± 0.60 
Myeloid cells 49.35 ± 5.30 1.51 ± 0.45 17.33 ± 7.71 0.97 ± 0.55 
Dendritic cells 2.39 ± 1.24 4.81 ± 9.83 2.41 ± 1.47 0.29 ± 0.17 
 
2) Thymus 
 
 Day 7 
% CD45.2 
 
% eYFP in CD45.2 
Day 14 
% CD45.2 
 
%eYFP in CD45.2 
ETP 64.88 ± 4.94 0.32 ± 0.11 2.15 ± 0.80 0.32 ± .023 
DN2 11.17 ± 2.15 0.04 ± 0.09 6.62 ± 2.4 0.04 ± 0.03 
DN3 4.29 ± 1.78 0 22.70 ± 8.63 0 
DN4 1.00 ± 0.83 0 2.12 ± 0.68 0 
DP 0.65 ± 0.75 0 48.24 ± 7.46 0 
SP CD4 0.13 ± 0.17 0 4.54 ± 0.92 0 
SP CD8 1.10± 0.71 0.62 ± 1.34 1.86 ± 0.57 0 
γδ T cells 2.57 ± 1.10 0.02 ± 0.01 0.36 ± 0.06 0.01 ± 0.01 
Dendritic cells 0.06 ± 0.08 0.01 ± 0.02 0.08 ± 0.06 0 
 
3) Bone Marrow 
 
 Day 7 
% CD45.2 
 
% eYFP in CD45.2 
Day 14 
% CD45.2 
 
%eYFP in CD45.2 
pro B cells 34.08 ± 4.71 33.70 ± 4.7 8.92 ± 3.78 8.64 ± 3.41 
pre B cells 18.41 ± 5.48 18.47 ± 6.0 21.35 ± 9.71 20.94 ± 8.47 
imm. B cells 8.40 ± 6.01 8.15 ± 5.47 8.58 ± 2.63 8.70 ± 2.58 
mat. B cells 0.75 ± 0.94 0.79 ± 0.64 4.23 ± 0.30 4.19 ± 0.31 
CLP 1.99 ± 1.31 0.28 ± 0.30 0.22 ± 0.32 0.05 ± 0.04 
Myeloid cells 31.25 ± 12.09 1.62 ± 1.11 3.59 ± 2.52 0.19 ± 0.08 
 
 
Transfer of 2 x 103 LMPP (B6.Mb1iCre/Gtrosa26eYFP) into CD45.1 Rag2-null (0.5 Gy irradiated) i.v. 
Supplementary Materials and Methods 
 
BCR re-arrangements detection and single cell PCR and RT-PCR 
Sample preparation: FACS-purified single, 5, 10 or 20 cells were collected into 
wells of 96-well plates containing either 20 µl of lysis buffer A (1x DreamTaqTM DNA 
Polymerase Buffer (Thermo Scientific), 0.01% Gelatin (Sigma)) for PCR on genomic 
IgH locus; or 20 µl of lysis buffer B (1.25x of M-MVL Reverse Transcriptase Reaction 
Buffer (Promega), 0.4 units/µl of RNasin (Promega), 0.3125% Igepal (Sigma)) for 
reverse-transcription PCR and detection of B cell- and macrophage-specific mRNA 
transcripts. Plates were frozen on dry ice immediately after sort and stored at -80°C.  
 
BCR re-arrangements detection by PCR: A multiplex PCR system was designed 
to amplify rearranged IgH genes from murine genomic DNA using nested PCR 
approach. Plates containg cells in 20 µl of lysis buffer A were thawed and briefly 
spun before addition of 1 µl of Protainase K (Invitrogen) to a final concentration of 
400 µg/ml and then incubated in Thermocycler (TECHNE) for 60 min at 55°C, 
followed by 10 min incubation at 95°C. First PCR step was performed with 11 outer 
forward primers, each specific to a group of functional IgHV genes, and 2 outer 
reverse primers specific to IgHJ genes (supplied by Sigma) (Table 1), using 0.125 µM 
of each primer, 3 µl of DreamTaqTM Buffer (1x), 0.25 µl of DreamTaqTM DNA 
Polymerase (Thermo Scientific), 1 µl of dNTPs (200 mM), 1 µl of 25mM MgCl2 (2.5 
mM) and 10 µl of 5x PCR enhancer (0.54 M Betaine, 1.34 mM DTT, 1.34% DMSO 
and 11 µg/ml BSA) per 50µl reaction, using the following PCR conditions: 2 min at 
95oC, 30 cycles of 15 sec at 95oC, 30 sec at 59.5oC and 30 sec at 72oC, 10 min at 
72oC on an Techne Thermocycler.  
 
Table 1. Primer sequences used for IgH amplification (1st PCR amplification)   
Primer ID Primer sequence  Tann  
VH-for1 GAGGTTCDSCTGCAACAGTY 
Outer 
forward 
primers 
 
 
 
 
 
59.5 °C 
 
 
 
 
 
 
 
 
59.5 °C 
 
   1st PCR  
 
Product size 
 ~300-400 
bp 
 
 
VH-for2 CAGGTGCAAMTGMAGSAGTC 
VH-for3 GAVGTGMWGCTGGTGGAGTC 
VH-for5 GAKGTGCAGCTTCAGSAGTC 
VH-for7 CAGRTCCAACTGCAGCAGYC 
VH-for8 GAGGTGMAGCTASTTGAGWC 
VH-for11 CAGATKCAGCTTMAGGAGTC 
VH-for12 CAGGCTTATCTGCAGCAGTC 
VH-for13 CAGGTTCACCTACAACAGTC 
VH-for14 CAGGTGCAGCTTGTAGAGAC 
VH-for15 GARGTGMAGCTGKTGGAGAC 
JH-1_rev CTTACCTGAGGAGACGGTGA 
Outer 
reverse 
primers JH-2_rev CTTACCTGCAGAGACAGTGA 
 
Obtained PCR products were diluted 1:10 with H2O and 1 µl was used for the second 
PCR reaction with 12 inner forward primers and 3 inner reverse primers (0.25 µM), 
using 2.5 µl of DreamTaqTM Green Buffer (1x), 0.125 µl of DreamTaqTM Green DNA 
Polymerase (Thermo Scientific), 0.5 µl of dNTPs (200 mM), 0.5 µl of 25mM MgCl2 
(2.5 mM)  and 5 µl of 5x PCR enhancer (0.54 M Betaine, 1.34 mM DTT, 1.34% 
DMSO and 11 µg/ml BSA) per 25 µl reaction. PCR was performed using the 
following conditions: 2 min at 95oC, 30 cycles of 15 sec at 95oC, 30 sec at 59oC and 
30 sec at 72oC, 10 min at 72oC on TECHNE Thermocycler. PCR products were 
analysed on 2% Agarose gel.  
 
Table 1 (continued). Primer sequences used for IgH amplification (2nd PCR 
amplification)  
Primer ID Primer sequence  Tann  
Inner_VH-for1 GGTTCDSCTGCAACAGTYWG 
Inner forward 
primers 
59.0 °C 
2nd PCR  
 
Product size 
~280-300 bp 
Inner_VH-for2 GGTGCAAMTGMAGSAGTCWG 
Inner_VH-for3 GTGMWGCTGGTGGAGTCTGG 
Inner_VH-for5 GTGCAGCTTCAGSAGTCWGG 
Inner_VH-for5_2 GTGCAGCTTCAGSAGTCGRG 
Inner_VH-for7 CTGAGCTGGTGARRCCTGG 
Inner_VH-for8 GTGMAGCTASTTGAGWCTGG 
Inner_VH-for11 CAGATKCAGCTTMAGGAGTCW
GGA 
Inner_VH-for12 CTGAGCTGGTGAGGC 
Inner_VH-for13 GTTCACCTACAACAGTCTGG 
Inner_VH-for14 GTGCAGCTTGTAGAGACCG 
Inner_VH-for15 TGMAGCTGKTGGAGACWGGA 
Inner_JH-1_rev CCAGACATCGAAGTACCAGT 
Inner reverse 
primers 
Inner_JH-2_rev GCCTTGACCCCAGTAGTC 
Inner_JH-3_rev GACAGTGACCAGAGTCCCTT 
  
 
Detection of B cell- and Mφ-specific mRNA transcripts by RT-PCR: Plates 
containg cells in 20 µl of lysis buffer B were thawed, briefly, spun, incubated at 70°C 
for 5 min and then cooled on ice. Random primers and Oligo(dT)15 Primers were 
incubated at 70°C for 5 min and then cooled on ice   before use. Reverse trancription 
reaction was performed on single and multiple cells using 1 µl of 500ng/µl Random 
Primers (Promega), 1 µl of 500 ng/µl Oligo(dT)15 Primer (Promega), 2 µl of 10 mM 
dNTPs and 0.5 µl M-MLV Reverse Transcriptase per 25 µl reaction using the 
following conditions: 5 min at 25oC, 60 min at 40oC and 10 min at  75oC. PCR 
amplification was performed using 10 µl of cDNA, 0.625 µl of forward and reverse 
Emr1 or Cd79b-specific primers (0.25 µM) (see Table 2), 2.5 µl of DreamTaqTM 
Green Buffer (1x), 0.125 µl of DreamTaqTM Green DNA Polymerase (Thermo 
Scientific), 0.5 µl of dNTPs (200 mM) and 0.75 µl of DMSO (3%) per 25µl reaction 
using the following conditions: 2 min at 95oC, 49 cycles of 15 sec at 95oC, 20 sec at 
specified annealing temperature (see Table 2) and 30 sec at 72oC, 10 min at 72oC on 
Techne Thermocycler. PCR products were analysed on 4% Agarose gel. 
Using PCR methods described above the following cell populations from naïve 
peritoneum were examined: B-1 B cells (CD19+ CD23- CD11b+ Gr1- F4/80-) and B-2 
B cells (CD19+ CD23+ CD11b- F4/80- ), naïve  CD19+ and CD19- pro-B cell-derived 
macrophages (F4/80high CD11bhigh YFP+), as well as yolk sac macrophages (F4/80high 
CD11bhigh YFP-) purified from B6.Mb1-iCre/Rosa26-YFP. At least 45 wells containing 
either single or multiple cells per well were analyse for each cell type.   
Table 2. Primer sequences used for RT-PCR 
Primer ID Primer sequence Tann Product size, bp 
Emr1_for GGAAGCCTCGTTTACAGGTG 
56.4°C 150 
Emr1_rev GGATGTACAGATGGGGGATG 
Cd79b_for GCTTTTTGGCTGCAAACCT 
54.1°C 95 
Cd79b_rev GGTACCAGCAATGACAAGCA 
 
Microarray analysis 
RNA was extracted from FACS-purified murine peritoneal cells populations using 
RNAZol (Moleclular Research Center, Inc.) and normalised to equal mass. Cell 
surface markers and relevant gating strategies used for cell purification are shown in 
Table 3 below and Fig. S15. Probe labeling and hybridization were performed using 
an Illumina Mus musculus 6v2 microarray as per manufacturer’s instructions. The 
array probe summaries for 30 datasets (n=3 per group) were calculated in 
BeadStudio (Illumina) and subsequently normalised by a variance stabilising 
transformation (VST) (1) and robust spline normalisation (RSN) using the lumi 
R/BioConductor package (2) (Fig. S16). Significantly differentially expressed genes 
were identified using the limma R/BioConductor package (3) to generate linear 
models for normalized probe intensity data, applying multiple t-tests between groups 
of sample replicates and selecting probes which gave Benjamini-Hochberg adjusted 
P-values < 0.001. Genes with very low or no expression among all samples 
compared were filtered out based on P-detection-value (> 0.01). Correlation analysis 
of the gene expression profiles of the individual cell populations and identification of 
co-expression modules were performed in Biolayout Express3D (4). The global gene 
expression profiles of the individual cell populations were compared using Pearson 
correlation threshold of r ≥ 0.97 in order to analyse the similarity between samples. A 
full probeset-to-probeset Pearson correlation matrix was calculated in Biolayout 
Express3D for each transcript represented on the array across the 30 samples using a 
correlation threshold of r ≥ 0.95. The graph was clustered using the MCL algorithm 
with an inflation value of 1.7 to generate clusters of genes with similar cell-specific 
activities. The network graph contained 11,216 nodes (probe sets representing 
specific transcripts) and after MCL-clustering (1.7) generated 272 distinct clusters 
containing ≥ 6 probe sets. The graph’s structure is presented in Fig. 6C. The 
microarray data are publicly available in ArrayExpress, accession number: E-MTAB-
1878. 
 
 
 
 
Table 3. Cell surface markers used for cell sorting  
Cell type Sorting strategy Source  
Follicular B-2 B cells B220+ CD23high CD21low Spleen 
C
57
B
L6
 m
ic
e Peritoneal B-1 B cells  CD19+ CD23- CD11bint F4/80- Peritoneum 
Peritoneal B-2 B cells CD19+ CD11b- CD23+ F4/80- Peritonitis 4h 
Monocytes 16h CD19- CD115+ Gr1int Peritonitis 16h 
Neutrophils 16h CD19- CD115- Gr1high CD11b+ Peritonitis 16h 
Naïve B-1/Mφs CD19- F4/80high CD11bhigh YFP+ Peritoneum 
B
6.
M
b1
-iC
re
/ 
R
os
a2
6-
Y
FP
 m
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MφTR-naïve  CD19- F4/80high CD11bhigh YFP- Peritoneum 
mo-Mφinflam CD19- F4/80high CD11bhigh YFP- PKH-
Red- 
Peritonitis 72h 
+ PKH-Red 
MφTR-inflam CD19- F4/80high CD11bhigh YFP- PKH-
Red+ 
pB-Mφinflam CD19- F4/80high CD11bhigh YFP+ PKH-
Red- 
pB-MφTR-inflam CD19- F4/80high CD11bhigh YFP+ PKH-
Red+ 
 
 
 
Hematopoietic cell isolation 
 
Peritoneal cells were obtained by lavage with 2 ml of PBS-based cell dissociation 
buffer (Invitrogen). Cells were centrifuged at 750 g for 4 min at 4⁰C and then red 
blood cells were depleted by incubation with 0.2 ml ACK lysing buffer (Lonza).  Lysis 
was stopped by addition 1 ml of 1% FCS 2 mM EDTA in PBS (FACS Buffer) and 
subsequent centrifugation. Cells were washed once more with 1 ml of FACS buffer 
and counted. Pleural cavity cells very harvested and processed similarly. Spleens 
were crushed between two glass slides in cold RPMI supplemented with 10% FSC 
and 100 units/ml of penicillin and 100 µg/ml of streptomycin (Invitrogen), obtained 
crude cell suspension was vigorously mixed by pipetting, passed through 70 µm cell 
strainer (BD Falcon) and centrifuged. Red blood cell lysis was performed as above 
using 4-5 ml of ACK buffer/spleen. Bone marrow cells were purified from femurs and 
tibiae, which were cleaned from surrounding muscle tissues, dipped in 70% ethanol 
for 0.5-1 min for disinfection. Then both ends of the bone were cut with scissors and 
the marrow flushed with 1% FCS 2 mM EDTA in PBS/RPMI using a syringe with a 
26G needle. Clusters within the marrow were disintegrated by vigorous pipetting. 
Red blood cells were lysed as above. Incubation with 10x volume of ACK lysing 
buffer (Lonza) was employed for peripheral blood cells purification, which was 
followed by washing with PBS and FACS Buffer. Small and large intestines were 
dissected from mice, washed of faecal content with cold HBSS and opened 
longitudinally. Tissue was then cut in 0.5 cm pieces and incubated twice in 5 ml of 
5% FCS, 2 mM EDTA, 1 mM DTT in HBSS for 20 min at 37⁰C on shaker (220 rpm) 
to remove epithelial cells. Then tissue was briefly washed with cold PBS and 
digested with 1.5 mg/ml Collagenase VIII (Sigma), 0.5 mg/ml DNase I (Sigma) and 1 
mg/ml Dispase II (Sigma) in Dulbecco’s PBS with Mg2+ and Ca2+ for 20 min at 37⁰C 
on shaker (220 rpm). After complete digestion cells were strained through 70 µm 
mesh and centrifuged. Cells were washed once more with 1% FCS 2 mM EDTA in 
PBS prior use. For brain and liver mononuclear cells analysis animals were perfused 
with 30 ml PBS via the left ventricle. Brain and liver were collected; tissues were 
sectioned and homogenized using a dounce homogenizer to obtain cell suspensions, 
which were filtered through 70 µm mesh and spun. Pellets were re-suspended in 5 
ml of 30% percoll, laid over 5 ml 70% percoll and centrifuged at 1000 g for 20 min at 
20ºC with low acceleration and no brake. Cells from interphase were collected using 
Pasteur pipette washed once in PBS and analysed by flow cytometry. 
 
Clonal assay 
S17 stromal cell lines were maintained in Iscove’s modified Dulbecco’s medium with 
20% (vol/vol) FCS, seeded into 96 well flat bottomed plates and were irradiated with 
30 Gy at 80% confluency. 24 h later, cells were washed and supplemented with 10% 
(vol/vol) FCS, 0.1 mM βmercaptoethanol and media containing growth factors for 
myeloid development (SCF [100ng/ml], Flt3L [5ng/ml], M-CSF [100ng/ml] and anti-
IL7 Ab [3µg/ml]) or lymphoid development (SCF, Flt3 and IL7 [10ng/ml]). Growth 
factors were from Peprotech with IL7 neutralizing antibody from R&D Systems.  Cells 
were sorted directly onto the stromal layers and were incubated for 10–14 d at 37 °C 
in 7.5% CO2, followed by flow cytometry. CD11b, Gr1, F4/80 and CD45 were used to 
discern myeloid cells while B220, CD19 and IgM were used for lymphoid cells. 
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